Nipro Stock

Nipro Liabilities

The The Liabilities of Nipro (8086.T) as of Aug 9, 2026 is 918.12 B JPY. In the previous year, The Liabilities was 877.16 B JPY — a change of 4.67% (higher).

Liabilities

918.12 BJPY

YoY

4.67%

Last updated:

In 2026, Nipro's total liabilities amounted to 918.12 B JPY, a 4.67% difference from the 877.16 B JPY total liabilities in the previous year.

Access this data via the Eulerpool API

Nipro Stock analysis

What does Nipro do? Nipro Corp is a Japanese company that was originally founded under the name Niki Shoji. The company was established in 1954 and initially produced steel pipes and accessories. In 1964, the company changed its name to Nipro Corp and expanded its business to the production of medical devices and instruments. Since then, Nipro Corp has become a major player in the global market for medical products and services. The business model of Nipro Corp is based on the design, manufacturing, and sale of a wide range of medical products, including dialysis machines, artificial organs, blood glucose meters, and infusion devices. The company is also active in the pharmaceutical and healthcare industries, offering various related services such as clinical trials. Nipro Corp is divided into various divisions, including Nipro Medical Corporation, which produces and sells the company's medical product range. This division is divided into three departments: dialysis technology, transfusion and infusion department, and the artificial organs department, which includes various products such as heart-lung machines and artificial kidneys. Another important division is Nipro Pharma Corporation, which focuses on the development, manufacturing, and sale of pharmaceuticals. The company has a strong presence in this division in the Asian market and is currently expanding into Europe and the United States. Another important area in which Nipro Corp is active is the manufacturing of glass and plastic products, particularly glass ampoules for storing medications and plastic products for medical use. In addition to its main business areas, Nipro Corp also offers a wide range of products and services for environmental technology, the semiconductor industry, and the electronics industry. The company is also involved in the production of solar energy products and has filed various patents in this field. Innovation and quality control are two important focuses of Nipro Corp. The company is heavily dedicated to researching and developing new products and technologies, as well as building strong business relationships with its customers. One of the key strategies of the company is to align its research and development activities with the needs of its customers and end-users to ensure that its products meet their requirements and expectations. Another focus of Nipro Corp is quality assurance and control. The company has a strict quality management system that is applied in all stages of the manufacturing process to ensure that its products meet the highest international standards. Overall, Nipro Corp has become a major player in the global market for medical products and services. With its wide range of products and services, focus on innovation and quality, and strong presence in the Asian market, the company is in a strong position to continue growing and evolving. Nipro is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Nipro's Liabilities

Nipro's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Nipro's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Nipro's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Nipro's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Nipro’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Nipro stock

The Liabilities of Nipro is 918.12 B JPY in 2026.

The Liabilities of Nipro changed from 877.16 B JPY to 918.12 B JPY, representing a 4.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Nipro since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Nipro historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Nipro

All Key Metrics — Nipro